Eric Hsu

Eric Hsu

Company: InMed Pharmaceuticals Ltd

Job title: Vice President - Preclinical, Research & Development


Panel Discussion: Meeting the Growing Demand for Cannabinoids for Research, Therapeutics & Consumer Products 1:00 pm

Identify new learnings that have been discovered in the discussion around phytocannabinoids vs synthetic Has the promise of biosynthesis been overestimated? Coach before the horse: What is the rationale in trying to explore new cannabinoids when many questions still remain about the therapeutic action of CBD and THC?Read more

day: Day One Track B - afternoon

Advances in Biosynthetic Cannabinoid Production of Rare Cannabinoids 11:00 am

Get an end-to-end view of how Inmed select a cannabinoid to pursue and the process that follows Discuss the upcoming cannabinoids the Inmed/ Baymedica team are looking to pursueRead more

day: Day One Track B - morning

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.